General Infectious Disease
WHO Global Arborvirus Initiative: Where do Infectious Disease Providers Play a Role?
- Variable Dose Thromboprophylaxis May Increase Survival in Patients With COVID-19
- Antibiotic Eradication of P aeruginosa Improves Long-Term Lung Function in CF
- Metformin, Ivermectin, and Fluvoxamine Do Not Prevent Severe COVID-19 Outcomes
- Risk for Uveitis After COVID-19 Vaccination Exists, But Is Low
- Hospital-Treated Infections Earlier in Life Tied to Alzheimer, Parkinson Disease Risk
- New-Onset Atrial Fibrillation Profiled in Patients Hospitalized With COVID-19
- Nutrition Labels to Move to Front of Packaging Under Biden Plan
- Canada to Remove All COVID-19 Border Restrictions October 1
- Fidaxomicin Is Superior to Vancomycin for Clostridioides difficile Infection
- Psychiatric Risks Subside Before Neurologic Risks After COVID-19
- Presence of Particulate Prompts Recall of Acyclovir Intravenous Product
- Chronic Liver Disease Mortality Rates Increased During COVID-19 Pandemic
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
ADT May Increase Risk of Death From Cardiovascular Disease in Prostate Cancer
Immunocompromised Patients With COVID-19 and Risk for ICU Admission, Mortality
Ustekinumab, Adalimumab Highly Efficacious for Treating Moderate to Severe Crohn Disease
COVID-19 Treatment: WHO Releases 11th Update to Living Guideline
Olfaction Impairment Patterns: COVID-19 vs Mild Cognitive Impairment
